Dr. Carol Routledge

Small Pharma Inc. (OTCQB: DMTTF), a biotech company that develops short-acting psychedelic-assisted therapies for depression, received approval from the U.K. Medicines and Healthcare products Regulatory Authority (MHRA) and the Research Ethics Committee to begin a Phase 1 clinical study...

Short-acting psychedelics company Small Pharma Inc. (OTCQB: DMTTF) has received the approval from the U.K. Medicines and Healthcare products Regulatory Authority (MHRA) and the Regional Ethics Committee for a drug interaction clinical trial to take place on national grounds. The novel study will...